Efficacy of trimethoprim, sulfamethoxazole and the combination of both in acute urinary tract infection. Clinical and pharmacokinetical studies.
作者信息
Koch U J, Schumann K P, Küchler R, Kewitz H
出版信息
Chemotherapy. 1973;19(5):314-21. doi: 10.1159/000221470.
PMID:4595635
Abstract
摘要
相似文献
1
Efficacy of trimethoprim, sulfamethoxazole and the combination of both in acute urinary tract infection. Clinical and pharmacokinetical studies.
Chemotherapy. 1973;19(5):314-21. doi: 10.1159/000221470.
2
Urinary tract infections: the efficacy of trimethoprim/sulfamethoxazole.尿路感染：甲氧苄啶/磺胺甲恶唑的疗效
Clin Ther. 1980;3(3):176-89.
3
Trimethoprim/sulfonamide: rational combination therapy.甲氧苄啶/磺胺：合理的联合治疗。
Compr Ther. 1976 May;2(5):55-63.
4
Sulfadiazine-trimethoprim combination in the treatment of urinary tract infections.
Chemotherapy. 1977;23(5):337-44. doi: 10.1159/000222003.
5
Relative efficacy of carbenicillin indanyl sodium and of trimethoprim/sulfamethoxazole in urinary-tract infections.
J Am Geriatr Soc. 1979 May;27(5):222-4. doi: 10.1111/j.1532-5415.1979.tb06036.x.
6
Trimethoprim-sulfamethoxazole vs sulfamethoxazole for acute urinary tract infections in children.
Am J Dis Child. 1978 Nov;132(11):1085-7. doi: 10.1001/archpedi.1978.02120360041005.
7
8
Long-term treatment of sulfa-resistant urinary tract infections with a sulfamethoxazole-trimethoprim combination.用磺胺甲恶唑-甲氧苄啶联合用药长期治疗耐磺胺类药物的尿路感染。
J Clin Pharmacol. 1978 Jan;18(1):54-60. doi: 10.1002/j.1552-4604.1978.tb01560.x.
9
Trimethoprim in vitro antibacterial activity is not increased by adding sulfamethoxazole for pediatric Escherichia coli urinary tract infection.复方磺胺甲噁唑并不能增强体外甲氧苄啶对小儿大肠埃希菌尿路感染的抗菌活性。
J Urol. 2010 Jul;184(1):305-10. doi: 10.1016/j.juro.2010.03.084. Epub 2010 May 20.
10
Comparison of trimethoprim in combination with sulfadiazine or sulfamethoxazole in the treatment of urinary tract infections.甲氧苄啶联合磺胺嘧啶或磺胺甲恶唑治疗尿路感染的比较。
J Postgrad Med. 1981 Jul;27(3):154-8.
引用本文的文献
1
Investigating the Mechanism of Trimethoprim-Induced Skin Rash and Liver Injury.研究甲氧苄啶引起皮疹和肝损伤的机制。
Toxicol Sci. 2021 Feb 26;180(1):17-25. doi: 10.1093/toxsci/kfaa182.
2
Bacterial resistance to trimethoprim.细菌对甲氧苄啶的耐药性。
Br Med J. 1980 Aug 30;281(6240):571-2.
3
Trimethoprim: a review of its antibacterial activity, pharmacokinetics and therapeutic use in urinary tract infections.甲氧苄啶：其抗菌活性、药代动力学及在尿路感染中的治疗应用综述
Drugs. 1982 Jun;23(6):405-30. doi: 10.2165/00003495-198223060-00001.
4
Bactericidal activity of trimethoprim alone and in combination with sulfamethoxazole on susceptible and resistant Escherichia coli K-12.甲氧苄啶单独及与磺胺甲恶唑联合使用对敏感及耐药大肠埃希菌K-12的杀菌活性。
Antimicrob Agents Chemother. 1982 Feb;21(2):288-93. doi: 10.1128/AAC.21.2.288.
5
Treatment of uncomplicated urinary tract infections with trimethoprim versus sulfisoxazole, with special reference to antibody-coated bacteria and fecal flora.用甲氧苄啶与磺胺异恶唑治疗单纯性尿路感染，并特别提及抗体包被细菌和粪便菌群。
Antimicrob Agents Chemother. 1981 May;19(5):842-50. doi: 10.1128/AAC.19.5.842.
6
Comparative efficacy and safety of nalidixic acid versus trimethoprim/sulfamethoxazole in treatment of acute urinary tract infections in college-age women.萘啶酸与甲氧苄啶/磺胺甲恶唑治疗育龄期女性急性尿路感染的疗效与安全性比较
Antimicrob Agents Chemother. 1981 Apr;19(4):598-604. doi: 10.1128/AAC.19.4.598.
7
Urinary tract infection in young children.幼儿尿路感染
Br Med J (Clin Res Ed). 1981 Aug 29;283(6291):614. doi: 10.1136/bmj.283.6291.614-a.
8
Single-dose and seven-day trimethoprim and co-trimoxazole in the treatment of urinary tract infection.单剂量及七日疗程的甲氧苄啶和复方新诺明治疗尿路感染
J R Coll Gen Pract. 1983 Sep;33(254):585-9.
9
Comparative in vitro activity of norfloxacin against urinary tract pathogens.诺氟沙星对泌尿道病原体的体外活性比较
Eur J Clin Microbiol. 1983 Jun;2(3):235-41. doi: 10.1007/BF02029524.
10
Co-trimoxazole toxicity.复方新诺明毒性
Br Med J (Clin Res Ed). 1985 Aug 17;291(6493):481. doi: 10.1136/bmj.291.6493.481.
Zotero 插件